N. Calvert et al., MEASLES IMMUNITY AND RESPONSE TO REVACCINATION AMONG SECONDARY-SCHOOLCHILDREN IN CUMBRIA, Epidemiology and infection, 116(1), 1996, pp. 65-70
The prevalence of antibody to measles virus in 759 children aged 11-18
years attending a secondary school in Cumbria was measured using a sa
livary Ige antibody capture assay. Serum IgG antibody levels were meas
ured using a plaque reduction neutralization assay in subjects whose s
aliva was antibody negative. Vaccination histories were obtained from
the child health computer and general practice records. A total of 662
pupils (87 % of those tested) had detectable measles-specific IgG in
saliva. Of the remaining 97, 82 provided blood samples and 29 had seru
m neutralizing antibody levels above 200 mU/ml. After adjusting for no
n-participation rates, the proportion considered non-immune (no IgG in
saliva and less than or equal to 200 mIU/ml in serum) was 9% overall,
ranging from 6% in vaccinated children to 20% in unvaccinated childre
n. Measles-mumps-rubella vaccine was given to 50 children of whom 38 p
rovided post-vaccination serum and 32 saliva samples. Thirty (79 %) ha
d a fourfold or greater rise in serum neutralizing antibody and 28 (88
%) developed IgG antibody in saliva. Half of the children considered
non-immune by antibody testing would have been overlooked in a selecti
ve vaccination programme targeted at those without a history of prior
vaccination. A programme targeted at all school children should substa
ntially reduce the proportion nonimmune since a primary or booster res
ponse was achieved in three quarters of previously vaccinated children
with low antibody levels and in all unvaccinated children. While it i
s feasible to screen a school-sized population for immunity to measles
relatively quickly using a salivary IgG assay, a simple inexpensive f
ield assay would need to be developed before salivary screening and se
lective vaccination could substitute for universal vaccination of popu
lations at risk of measles outbreaks. The salivary IgG assay provided
a sensitive measure of a booster response to vaccination.